Elon Musk’s Neuralink isn’t the only contender in the brain-tech race. Paradromics has entered the arena with its first human ...

Paradromics Inc. completed its first human procedure with the Connexus BCI, marking a milestone in brain-computer interface ...

Paradromics, a brain-computer-interface startup, inserted its brain implant in a person—briefly—in an early test of its ...

Paradromics implanted—then removed—the device in an epileptic patient. The goal is to help people with conditions like ALS.

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Neurotech startup Paradromics announced it has successfully implanted its brain-computer interface (BCI) in a human for the ...

While Elon Musk’s Neuralink is the most well-funded of the group, other companies working on computer-brain interfaces have ...

Elon Musk's brain-computer interface company Neuralink has raised $600 million in new funding at a $9 billion valuation, according to Semafor. The fundraising round follows the company's first human ...

Neuralink competitor Paradromics plans to conduct the first clinical trial of its Connexus brain implant later this year.

Neuralink, Elon Musk’s brain-computer interface (BCI) startup, raised US$650M in its latest Series E funding round.

A 20-minute surgery marks a historic turning point for Paradromics as it begins its transition to clinical-stage neurotech.

Neuralink raised $650M in Series E funding to advance brain-computer tech, with global trials and new use cases now underway.